Complement-Based Drug Development Summit leaderboard
  • Monday, August 31, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 411

Author

Pharma Journalist 9027 posts 0 comments

WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China

Mar 16, 2021
WuXi Biologics announced that it has entered into an equity agreement with Pfizer China to acquire its state-of-the-art biologics manufacturing facilities as well as its labor force in…
Read More...

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric…

Mar 16, 2021
Nurix Therapeutics, Inc. a biopharmaceutical company developing targeted protein modulation drugs,  announced that it is part of a collaboration sponsored by Alex’s Lemonade Stand…
Read More...

Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory…

Mar 16, 2021
Ampio Pharmaceuticals a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, recently revealed preliminary positive…
Read More...

Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine

Mar 16, 2021
Takeda Pharmaceutical Company Limited announced a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization, to utilize capacity at IDT previously…
Read More...

Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting,…

Mar 16, 2021
Gilead Sciences, Inc. and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement to co-develop and co-commercialize…
Read More...

New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in…

Mar 16, 2021
Novartis announced new data that reinforce the transformational benefit of Zolgensma (onasemnogene abeparvovec), an essential one-time treatment for spinal muscular atrophy (SMA). The…
Read More...

Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS (voclosporin) in Latest ICER…

Mar 16, 2021
Aurinia Pharmaceuticals Inc. announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS (voclosporin), based on an independent analysis issued by the…
Read More...

Explore opportunities and strategies for convergence in the combination products space at Pre-Filled…

Mar 15, 2021
SMi Reports: Gain insights into the industry acceleration towards connectivity following the pandemic through case studies on connected devices and virtual studies. Key Themes for…
Read More...

Exclusive Interview with David Guest, MHRA ahead of Parallel Trade Conference 2021

Mar 15, 2021
SMi Reports: SMi Group is proud to introduce some insightful content from expert speaker of the upcoming Parallel Trade conference, taking place 22nd – 23rd March. The conference…
Read More...

HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis…

Mar 15, 2021
HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. (TBUSA) announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • FDA Approves Tivicay PD for Infants With HIV
  • FDA Grants Rare Pediatric Disease Designation to ReviR’s RTX-117
  • FDA Approves Ziihera Combinations for HER2-Positive GEA
  • FDA Approves RASONQUE for Metastatic Pancreatic Cancer
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.